Complex polypharmacy in bipolar disorder: Side effect burden, adherence, and response predictorsVicki Fung, Andrew A. Nierenberg, Lindsay Overhage et al.|Journal of Affective Disorders|2019Cited by 44
Studying pre-treatment and ketamine-induced changes in white matter microstructure in the context of ketamine’s antidepressant effectsValerie J. Sydnor, Marek Kubicki, Amanda E. Lyall et al.|Translational Psychiatry|2020Cited by 32
Familial severe psychiatric history in bipolar disorder and correlation with disease severity and treatment responseOle Köhler‐Forsberg, Andrew A. Nierenberg, Valerie L. Ruberto et al.|Journal of Affective Disorders|2020Cited by 16
A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methodsMarie‐Louis Wronski, Elizabeth A. Lawson, Franziska Plessow et al.|Contemporary Clinical Trials|2022Cited by 13
Adjunctive antidepressant treatment among 763 outpatients with bipolar disorder: Findings from the Bipolar CHOICE and LiTMUS trialsOle Köhler‐Forsberg, Andrew A. Nierenberg, Louisa G. Sylvia et al.|Depression and Anxiety|2020Cited by 8